Antiproliferative effect of sera from chagasic patients on Trypanosoma cruzi epimastigotes. Involvement of xanthine oxidase

Acta Tropica

Volumn 109, Issue 3, 2009, Pages 219-225

  Hernandez, Susana M ^a   Kolliker Frers, Rodolfo A ^b   Sanchez, Marcela S ^c   Razzitte, Gabriela ^b   Britos, Rodny D ^a   Fuentes, Maria E ^a   Schwarcz de Tarlovsky, Martha N ^a  

^a UNIVERSIDAD ABIERTA INTERAMERICANA   (Argentina)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Chagas disease; Hydrogen peroxide; Reactive oxygen species; Trypanosoma cruzi; Xanthine oxidase

Indexed keywords

ALLOPURINOL; CATALASE; HYDROGEN PEROXIDE; XANTHINE OXIDASE;

ANTIBODY; CHAGAS DISEASE; ENZYME ACTIVITY; HYDROGEN PEROXIDE; PROTOZOAN; SERUM;

ARTICLE; CATALYST; DRUG EFFECT; ENZYME ACTIVITY; EPIMASTIGOTE; HUMAN; LIPID MEMBRANE; LIPID PEROXIDATION; TRYPANOSOMA CRUZI;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; CHAGAS DISEASE; HUMANS; HYDROGEN PEROXIDE; SERUM; TRYPANOSOMA CRUZI; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

TRYPANOSOMA CRUZI;

EID: 59049104572     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.11.013     Document Type: Article

References (33)

1. Almeida I.C., Ferguson M.A.J., Schenkman S., and Travassos L.R. Lytic anti-α-galactosil antibodies from patients with chronic Chagas disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glyproteins of Trypanosoma cruzi. Biochem. J. 304 (1994) 793-802
2. Altcheh J., Corral R., Biancardi M., and Freilij H. Anticuerpos anti-F2/3 como marcador de curación en niños con infección congénita por Trypanosoma cruzi. Medicina 63 (2003) 37-44
3. Antunez M., and Cardoni R. IL-12 and INF γ production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunol. Lett. 71 (2000) 103-109
4. Berry C.E., and Hare J.M. Xantine oxidoreductase and cardiovascular disease. Mechanism and physiological implications. J. Physiol. 555 (2004) 589-606
5. Black S., Sicard E., Murphy N., and Nolan D. Innate and acquired control of trypanosome parasitaemia in Cape Buffalo. Int. J. Parasitol. 31 (2001) 562-565
6. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
7. Cardoni R. La respuesta inflamatoria en la infección aguda con Trypanosoma cruzi. Medicina 57 (1997) 227-234
8. Cardoni R., Antunez M., and Abrami A. Respuesta TH1 en la infección experimental con Trypanosoma cruzi. Medicina 59 (1999) 84-90
9. Cross G.A.M. Cellular and genetic aspect of antigenic variation in Trypanosome. Annu. Rev. Immunol. 8 (1990) 83-110
10. Desco M.C., Asensi M., Marquez R., Martinez-Valls J., Vento M., Pallardo F.V., Sastre J., and Viña J. Xanthine oxidase is involved in free radical production in type 1 diabetes. Protection by allopurinol. Diabetes 5 (2002) 1118-1128
11. Drain J., Bishop J., and Hajduk S. Haptoglobine-related protein mediates trypanosome lytic factor binding to trypanosomes. J. Biol. Chem. 32 (2001) 30254-30260
12. Flohe L., and Otting F. Superoxide dismutase assays. Methods Enzymol. 105 (1984) 93-104
13. Freshney R.L. The Culture of Animal Cells: A Manual of Basic Technique. 3rd ed. (1994), Wiley-Liss, NY, USA
14. Gazzinelli R.T., and Pereira M.E. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. J. Eukaryot. Microbiol. 41 (1994) 47-57
15. Hernandez S.M., Sanchez M.S., and Schwarcz de Tarlovsky M.N. Polyamine as a defense mechanism against lipoperoxidation in Trypanosoma cruzi. Acta Trop. 98 (2006) 94-102
16. Ismail S.O., Paramchuk W., Skeiky Y., Reed S., Bhatia A., and Gedamu L. Molecular cloning and characterization of two iron superoxide dismutase cDNAs from Trypanosoma cruzi. Mol. Biochem. Parasitol. 86 (1997) 187-197
17. Laveran A., and Mesnil F. In: Masson S. (Ed). Trypanosomes et trypanosomiases (1912)
18. Machado C., Augusto-Pinto L., McCulloch R., and Teixeira S. DNA metabolism and genetic diversity in Trypanosomes. Mut. Res. 612 (2006) 40-57
19. Martin H., Hancock J., Salisbury V., and Harrison R. Role of xanthine oxidoreductase as an antimicrobial agent. Infect. Immun. 72 (2004) 4933-4939
20. Molina Portela M., Raper J., and Tomlinsom S. An investigation into the mechanism of Trypanosome lysis by human factors. Mol. Biochem. Parasitol. 110 (2000) 273-282
21. Muranjan M., Wan Q., Li Y., Hamilton E., Otieno-Omondi F.P., Wang J., Van Praagh A., Grootenhuis J.G., and Black S.J. The trypanocidal Cape Buffalo serum protein is xanthine oxidase. Infect. Immun. 65 (1997) 6806-6814
22. Nabors G., and Tarleton R. Differential control of IFN-γ and IL-2 production during Trypanosoma cruzi infection. J. Immunol. 146 (1991) 3591-3598
23. Pays E., Vanhollebeke B., Vanhamme L., Paturiaux-Hanocq F., Nolan D., and Perez-Morga D. The trypanolytic factor of human serum. Nat. Rev. Microbiol. 4 (2006) 477-486
24. Pompella A., Maellaro E., Casini A.F., Ferrali M., Ciccoli L., and Comporti M. Measurement of lipid peroxidation in vivo: a comparison of different procedures. Lipids 22 (1987) 206-211
25. Raper J., Fung R., Ghiso J., Nussenweig V., and Tomlinson S. Characterization of novel trypanosome lytic factor from human serum. Infect. Immun. 67 (1999) 1910-1916
26. Raper J., Portela M.P., Lugli E., Freverd U., and Tomlinson S. Trypanosome lytic factors: novel mediators of human innate immunity. Curr. Opin. Microbiol. 4 (2001) 402-408
27. Samudio M., Montenegro-James S., Cabral M., Martinez J., Rojas de Arias A., and James M. Cytokine responses in T. cruzi infected children in Paraguay. Am. J. Trop. Med. Hyg. 58 (1998) 119-121
28. Vanhamme L., and Pays E. The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness. Int. J. Parasitol. 34 (2004) 887-898
29. Vorbach C., Harrison R., and Capecchi M.R. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol. 24 (2003) 512-517
30. Wang Q., Murphy N., and Black S.J. Infection-associated decline of Cape Buffalo blood catalase augments serum trypanocidal activity. Infect. Immun. 6 (1999) 2797-2803
31. Wen J.J., Vyatkina G., and Garg N. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Rad. Biol. Med. 37 (2004) 1821-1833
32. World Health Organization, 2002. Control of Chagas disease: Second report of the World Health Organization expert committee Strategic Direction for Research Geneva, Switzerland, pp. 1-159.
33. Zacks M., Wen J., Vyatkina G., Bhatia V., and Garg N. An overview of chagasic cardiomyopathy. Pathogenic importance of oxidative stress. Anais da Acad. Bras. de Ciencias 77 (2005) 695-714